Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective and Non-Selective Endothelin-Receptor Blockade in Coronary Artey Disease

NCT00427232 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT00427232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00427232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective and Non-Selective Endothelin-Receptor Blockade in Coronary Artey Disease
Lead sponsor
Medical University of Vienna
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2003
Completion date
August 31, 2006
Enrollment
26
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary vessels, endothelins, vascular resistance